Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| TCHSTRATEGY | K-CHX | |
|---|---|---|
| Held by both | ||
| Cambricon | 2.60% | 3.25% |
| Only in TCHSTRATEGY | ||
| WuXi Biologics | 4.37% | N/A |
| 4.07% | N/A | |
| 3.63% | N/A | |
| Innovent | 3.24% | N/A |
| Only in K-CHX | ||
| N/A | 8.09% | |
| N/A | 6.58% | |
| Zhongji Innolight | N/A | 4.62% |
| N/A | 3.43% | |
30 Dec 2025 → 3 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TCHSTRATEGY | −2.03% | 27.93% | −0.07 |
| K-CHX | −15.73% | 17.80% | −0.88 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | TCHSTRATEGY | K-CHX |
|---|---|---|
Fund details | ||
| Fund size | 29.52 million | 1,293 million |
| Inception date | 10 Aug 2022 | 8 Sep 2015 |
| Master fund | กองทุนที่ลงทุนหลายกอง | CSOP FTSE China A50 ETF (RMB) |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 6 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 86.42% | 94.55% |
Minimum purchase and redemption | ||
| First purchase | 1,000 THB | 500 THB |
| Subsequent purchase | 1,000 THB | 500 THB |
| Redemption (amount) | No minimum | 500 THB |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | 50 THB |
| Balance (units) | 100 units | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:00 | 14:00 |
| Redeem before | 15:00 | 14:00 |
| Redemption paid | T+4 | T+3 |